Venus Remedies informs about unaudited financial results

25 Nov 2023 Evaluate
Venus Remedies has enclosed pdf copy of Unaudited financial results for the quarter ended on 30.09,2023 along with limited review report.

The above information is a part of company’s filings submitted to BSE.

Venus Remedies Share Price

736.00 14.60 (2.02%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×